A(z) IgA Nephropathy csatorna legjobb podcastjai (2024)

1
All Hands on Deck in Cervical Cancer Care: Screening, Treatment, and Equity Strategies to Improve Patient Lives 1:00:36

9d ago1:00:36

1:00:36

The reduced incidence of cervical cancer over the past few decades was primarily due to robust screening guidelines and vaccinations. However, despite the proliferation of screening programs, the diagnosis of cervical cancer is associated with inefficiencies and inconsistencies and has not decreased cervical cancer incidence further over the past d…

1
All Hands on Deck – Utilizing JAK Inhibitors in Myelofibrosis Care: Evidence, Timing, and Strategic Approaches 46:40

9d ago46:40

46:40

Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway inhibition is the standard of care for patients with symptomatic myelofibrosis (MF); however, a significant number of hematologists/oncologists lack knowledge, competence, and confidence about JAK inhibitors (JAKis) in MF. These clinicians and their interdisciplinary c…

1
Updates on Renal Denervation From the 2024 European Society of Cardiology Guidelines on Hypertension 24:36

16d ago24:36

24:36

What’s changed in how we should manage resistant hypertension? Credit available for this activity expires: 9/30/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001663?ecd=bdc_podcast_libsyn_mscpedu

1
Hidden Unmet Needs in Schizophrenia: What Every Healthcare Professional Needs to Know 18:59

16d ago18:59

18:59

Lively Quickfire session on helping patients with cognitive and negative symptoms. Credit available for this activity expires: 9/30/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001571?ecd=bdc_podcast_libsyn_mscpedu

1
Spotlight on Liver MRI: Diagnosing and Managing Hepatocellular Carcinoma 33:45

20d ago33:45

33:45

In the face of the rising incidence of liver disease, how is your multidisciplinary team using imaging for surveillance and management of patients with hepatocellular carcinoma (HCC)? Credit available for this activity expires: 9/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001653?ecd=bdc_podcast_libs…

1
A Prospective Study of Depression and Quality of Life After Kidney Transplantation 3:46

20d ago3:46

3:46

In an analysis of patients undergoing kidney transplantation, depression and health related quality of life were measured at 3-months and 1-year post-transplantation. Depression and HRQOL improve with KT.American Society of Nephrology által

1
Modeling Guideline-Concordant Therapy Selection in the Adjuvant Setting for Endometrial Cancer 28:24

21d ago28:24

28:24

Do you know the best approaches to managing patients with endometrial cancer in the adjuvant setting? Credit available for this activity expires: 9/24/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001649?ecd=bdc_podcast_libsyn_mscpedu

1
Anticoagulation in AF with Cirrhosis, Trends in Anticoagulation for Acute PE, Beta Blockers for Acute MI with Normal EF, Finerenone for HFpEF, Continuous vs Intermittent Infusion for Antibiotics, Cefepime ... 1:05:23

22d ago1:05:23

1:05:23

It's been a long time, but we are back! Apologies on the audio quality from Dr. Jenkins. Apparently he was recording from inside a cardboard box. Today we talk about important, practice changing studies in internal medicine from the last several months. What's the best anticoagulant in patients with cirrhosis and atrial fibrillation? Why do doctors…

1
Evolution of HER2-Targeted Therapy in Biliary Tract Cancer 24:04

26d ago24:04

24:04

Do you know which type of biliary tract cancer (BTC) has the highest rate of HER2 aberrations? Credit available for this activity expires: 9/20/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001632?ecd=bdc_podcast_libsyn_mscpedu

1
Spotlight on Liver MRI: Fatty Liver Disease 26:08

30d ago26:08

26:08

How does magnetic resonance imaging (MRI) play a role in identifying biomarkers for patients with steatotic liver disease? Credit available for this activity expires: 9/13/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001595?ecd=bdc_podcast_libsyn_mscpedu…

1
Board Review Bonus #2: Minimal Change Disease 24:56

1M ago24:56

24:56

In this special bonus episode of the podcast, Koyal and Kenar provide a maximally useful review of minimal change disease, from diagnosis (including secondary causes to screen for) to treatment options, including how to decide which patients may do better with which therapies. Can’t get enough minimal change? Check out Episode 6 (with Astrid Weins)…

1
Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team 1:18:51

1M ago1:18:51

1:18:51

The treatment paradigm in bladder cancer has fundamentally changed over the past decade, and the evolving, dense clinical trial landscape has given rise to barriers to optimizing patient care. This webcast will focus on emerging trial data for antibody-drug conjugates (ADCs); sequence optimization, combinatorial therapy utilization, and identificat…

1
Paradigm Shifting Updates in IgAN: Expert Faculty Discussions of Recent Breakthroughs 18:20

1M ago18:20

18:20

In this CCO Nephrology podcast episode, hear from nephrologists Pietro Canetta, MD, MS, and Andy Bomback, MD, PhD, experts in clinical management and research on glomerular diseases as they discuss key updates in managing IgAN. Faculty highlight the importance of a comprehensive supportive care regimen to protect patients’ kidneys and prevent progr…

1
Cognition in Psychiatry and Schizophrenia: All You Need to Know in 15 Minutes 19:39

2M ago19:39

19:39

What is processing speed? Does it matter? Learn why it absolutely does for your patients. Credit available for this activity expires: 8/3/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001439?ecd=bdc_podcast_libsyn_mscpedu

1
Data Highlights in Alzheimer's Disease From the 2024 AAIC Annual Meeting 28:48

2M ago28:48

28:48

What's ready for prime time and what's in the pipeline in Alzheimer’s disease (AD) diagnosis and care? View conference highlights to find out. Credit available for this activity expires: 8/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001535?ecd=bdc_podcast_libsyn_mscpedu…

1
Mastering Multiplex Testing for Diagnosing Pneumonia: From Interpretation to Application 31:49

2M ago31:49

31:49

Delve into the impact of revolutionary multiplex testing for diagnosing pneumonia. Credit available for this activity expires: 8/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001528?ecd=bdc_podcast_libsyn_mscpedu

1
Expert Perspectives on the Future of IgA Nephropathy Treatment 30:26

2M ago30:26

30:26

Recent advances in our understanding of immunoglobulin A (IgA) nephropathy (IgAN) have led to an abundance of research into new therapies; our experts will guide you through it all. Credit available for this activity expires: 8/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001534?ecd=bdc_podcast_libsyn…

1
Breaking Down the Burden of IgA Nephropathy With Clinician and Patient Perspectives 18:01

2M ago18:01

18:01

Are your patients' kidneys fighting a silent battle? Our experts give insight on earlier detection of IgAN and react to a real patient's experience. Credit available for this activity expires: 8/23/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001513?ecd=bdc_podcast_libsyn_mscpedu…

1
Expert Discussions: Novel Agents Targeting Residual Inflammatory Risk in ASCVD and CKD 15:28

2M ago15:28

15:28

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they discuss new and emerging therapies designed to target residual inflammatory risk associated with ASCVD and CKD.    Episode outline:   Colchicine: inhibition of NLRP3 inflammasome assembly/…

1
Expert Discussions on Residual Systemic Inflammation in ASCVD and CKD 14:32

2M ago14:32

14:32

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore new and emerging strategies to target residual risk associated with systemic inflammation in patients with ASCVD and CKD.    Episode outline:   The relationship among systemic infl…

1
Expert Discussions: Moving Beyond Lipid Lowering to Lower Risk in ASCVD and CKD 14:32

2M ago14:32

14:32

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore the pathophysiology and novel therapeutic strategies to target residual inflammatory risk associated with ASCVD and CKD.    Episode outline:   Moving beyond lipid lowering to addre…

1
Putting Data Into Context for Congenital Adrenal Hyperplasia Treatment Advances 26:39

2M ago26:39

26:39

Do you have the latest data on novel therapies for congenital adrenal hyperplasia (CAH)? An expert panel discusses. Credit available for this activity expires: 8/23/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001510?ecd=bdc_podcast_libsyn_mscpedu

1
Don't Go With Your Gut: Optimizing GI Infection Management With Rapid Diagnostic Panels 32:03

2M ago32:03

32:03

How much do you know about rapid molecular diagnostics for gastrointestinal (GI) infections? Credit available for this activity expires: 08/13/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001464?ecd=bdc_podcast_libsyn_mscpedu

1
Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer 50:54

2M ago50:54

50:54

Patients with triple-negative and HR-positive/HER2-negative breast cancer have limited treatment options after the development of endocrine resistance. This dearth of options is particularly acute for Black women and other marginalized patients and results in treatment disparities. Antibody-drug conjugates (ADCs) are novel agents which may improve …

1
Transforming Metastatic Breast Cancer Management: Harnessing the Power of Antibody-Drug Conjugate Therapies 1:33:21

2M ago1:33:21

1:33:21

Patients with triple-negative breast cancer (TNBC), and those with HR-positive/HER2-negative breast cancer after the development of endocrine resistance, have limited treatment options. Black women are diagnosed more often with TNBC and feel the lack of treatment options more acutely, leading to greater outcomes disparities. Antibody-drug conjugate…

1
The Multiple Layers of Major Depressive Disorder Management: Unravelling the Who, When, and How for Antidepressant Modification 48:51

3M ago48:51

48:51

What do you do when your patients are unravelling due to their antidepressant? Credit available for this activity expires: 7/26/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001393?ecd=bdc_podcast_libsyn_mscpedu

1
Navigating New Waters for Advanced or Recurrent Endometrial Cancer 1:06:48

3M ago1:06:48

1:06:48

Patient prognosis for endometrial cancer (EC) is highly benefited by molecular profiling, and national and international guidelines robustly recommend its integration into practice. Characterization of DNA mismatch repair (MMR) status identifies clinically significant molecular subtypes. This information assists clinicians in creating treatment pla…

1
Exploring Innovations in Lung Cancer Care: Updates From Chicago 35:05

3M ago35:05

35:05

Get the latest information on new lung cancer data from Chicago. Credit available for this activity expires: 7/22/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001363?ecd=bdc_podcast_libsyn_mscpedu

1
Key Clinical Characteristics of IgA Nephropathy to Apply in Practice 33:44

3M ago33:44

33:44

Dive into the fascinating world of immunoglobulin A nephropathy (IgAN), the most common form of primary glomerulonephritis worldwide. Credit available for this activity expires: 7/16/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001351?ecd=bdc_podcast_libsyn_mscpedu…

1
Board Review Bonus #1: IgA Nephropathy 27:49

3M ago27:49

27:49

SHOW NOTES In this episode, Koyal and Kenar recap everything you need to know about IgAN for the board exam (or just to refresh yourself on the current state of knowledge) — from pathophysiology to treatment decisions. They also discover that nobody is really sure how to pronounce Peyer’s patches (hey, don’t blame us, they’re all the way over in th…

1
Building Confidence in Care: Strategies to Address Vaccine Hesitancy in Hispanic Communities 24:17

3M ago24:17

24:17

Are you providing culturally competent care for your Hispanic patients? Credit available for this activity expires: 7/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001327?ecd=bdc_podcast_libsyn_mscpedu

1
Navigating IgA Nephropathy: Insights From a Patient With Lived Experience 21:53

3M ago21:53

21:53

In this CCO Nephrology podcast episode, hear from Kelly Chen, a nephrology nurse practitioner and patient living with IgA nephropathy, as she discusses her experiences with Dr Pietro Canetta, Associate Professor of Medicine at Columbia University and expert in glomerular diseases. Episode outline: Seeking and obtaining an IgAN diagnosis Patient sel…

1
Navigating Relapsed/Refractory CLL/SLL Together: Where Disease-, Treatment-, and Patient-Centered Care Unite 1:14:02

3M ago1:14:02

1:14:02

Did you know 59% of patients value doctors asking about their information needs and desired level of care involvement? Join us to explore these and other insights in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL). Credit available for this activity expires: 7/5/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.o…

1
Navigating Patient-Centered Care of CLL and MCL: Empowering Collaboration and Communication 52:08

4M ago52:08

52:08

Are you aware of the DREAM protocol that can facilitate a 2-way exchange between patients and clinicians? Credit available for this activity expires: 6/28/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001200?ecd=bdc_podcast_libsyn_mscpedu

1
Unmasking Cognitive Impairment and Negative Symptoms in Schizophrenia 38:18

4M ago38:18

38:18

Short on time? You can still screen for these function-limiting symptoms. Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001208?ecd=bdc_podcast_libsyn_mscpedu

1
What's on the Horizon in Atopic Dermatitis? A Focus on OX40-OX40 Ligand-Targeted Therapies 29:15

4M ago29:15

29:15

Did you know that targeting the OX40-OX40 ligand (OX40-OX40L) pathway may lead to long-term remission in atopic dermatitis (AD)? Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001214?ecd=bdc_podcast_libsyn_mscpedu…

1
Expert Opinions on Treating Metabolic Dysfunction-Associated Steatohepatitis 17:29

4M ago17:29

17:29

How would you manage a patient with metabolic syndrome and metabolic dysfunction-associated steatohepatitis? Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001260?ecd=bdc_podcast_libsyn_mscpedu

1
Connecting With the Experts at ASCO 2024: Clinical Pearls and Data Insights About Anti-HER2 Therapies in Biliary Tract Cancer 24:15

4M ago24:15

24:15

Get the latest data from ASCO 2024 about anti-HER2 therapies in biliary tract cancer. Credit available for this activity expires: 6/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001250?ecd=bdc_podcast_libsyn_mscpedu

1
Life With Cardiac Amyloidosis 19:40

4M ago19:40

19:40

Are you aware of patients’ perceptions and wishes about diagnosis and management of transthyretin amyloid cardiomyopathy (ATTR-CM)? Credit available for this activity expires: 6/18/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001176?ecd=bdc_podcast_libsyn_mscpedu…

1
Quiz Time! Test Your Knowledge on Treatments for Gastroesophageal Reflux Disease 1:12:31

4M ago1:12:31

1:12:31

How much do you know about new acid suppressive treatments for gastroesophageal reflux disease (GERD)? Credit available for this activity expires: 6/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001195?ecd=bdc_podcast_libsyn_mscpedu

1
What's New in the Treatment of Gastroesophageal Reflux Disease and Erosive Esophagitis: Spring Meeting Updates 1:12:31

4M ago1:12:31

1:12:31

Hear from 3 experts as they discuss the latest clinical knowledge on the management of gastroesophageal reflux disease (GERD) and erosive esophagitis. Credit available for this activity expires: 6/11/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001184?ecd=bdc_podcast_libsyn_mscpedu…

1
EHA2024 Chronic Lymphocytic Leukemia Preview: The Road Ahead With Targeted Therapies 33:47

4M ago33:47

33:47

Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1…

1
There Are Multiple Ways to Treat R/R CLL or R/R MCL: What Would the Experts Do? 59:02

4M ago59:02

59:02

Listen to the experts discuss treatment options for relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and R/R mantle cell lymphoma (MCL) in 4 unique patient cases. Credit available for this activity expires: 06/07/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000852?ecd=bdc_podcast_libsyn_mscpe…

1
Multiple Sclerosis Biosimilars in the United States: How to Communicate With Your Patient for Successful Implementation 19:25

4M ago19:25

19:25

Do you know how to have a heads-up conversation about biosimilars? Credit available for this activity expires: 6/6/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001162?ecd=bdc_podcast_libsyn_mscpedu

1
Episode 7: Felicitas Hengel and Nicola Tomas on a New Chapter in Anti-Nephrin Autoantibodies 16:15

4M ago16:15

16:15

In this episode, we talk with Dr. Felicitas Hengel, MD and Dr. Nicola Tomas, MD (both at the University Medical Center Hamburg-Eppendorf) about their groundbreaking anti-nephrin autoantibody research that was just presented at the 2024 ERA Congress and published in the New England Journal of Medicine. Is this a game-changer for minimal change? How …

1
To Switch or Not to Switch: Patient Case Discussions on Integrating Biosimilars in Multiple Sclerosis Care 29:22

4M ago29:22

29:22

What are the main indicators that a patient with multiple sclerosis (MS) can be switched to a biosimilar? Credit available for this activity expires: 5/31/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000864?ecd=bdc_podcast_libsyn_mscpedu

1
Enhancing Equitable HIV Care With Long-Acting Injectable Antiretrovirals: Why It Matters 20:03

4M ago20:03

20:03

Are you doing all you can to provide equitable care to persons with HIV or those at risk for HIV infection? Credit available for this activity expires: 5/31/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001139?ecd=bdc_podcast_libsyn_mscpedu

1
International Expert Recommendations for Timely and Accurate Diagnosis of Alzheimer's Disease in Primary Care 41:25

5M ago41:25

41:25

What is the primary care clinician's role in diagnosing early stages of Alzheimer's disease, and what kinds of assessments can they use? Credit available for this activity expires: 5/31/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000858?ecd=bdc_podcast_libsyn_mscpedu…

1
Case Study in Managing in MASLD/MASH 19:04

5M ago19:04

19:04

How would you manage this patient? Credit available for this activity expires: 5/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001135?ecd=bdc_podcast_libsyn_mscpedu

1
Episode 6: Astrid Weins on Anti-Nephrin Antibodies and Nephropathology 17:23

5M ago17:23

17:23

In this episode, Kenar and Koyal interview Dr. Astrid Weins, MD, PhD, about nephropathology, new approaches to solving the mysteries of nephrotic syndrome, and her research on anti-nephrin antibodies in minimal change disease. Dr. Weins is Chief of Integrated Renal Pathology at Mass General/Brigham and an Assistant Professor of Pathology at Harvard…

Podcastok, amelyeket érdemes meghallgatni

IgA Nephropathy Podcastok

Podcastok, amelyeket érdemes meghallgatni

Gyors referencia kézikönyv